Onfi™ (clobazam) tablets now available in the US at retail pharmacies
3 January 2012 | By H. Lundbeck A/S
Lundbeck announced that Onfi tablets are now available for prescribing in the United States...
List view / Grid view
3 January 2012 | By H. Lundbeck A/S
Lundbeck announced that Onfi tablets are now available for prescribing in the United States...
22 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced today that the US Food and Drug Administration (FDA) has determined that a new drug application (NDA) for Otsuka's investigational once-monthly aripiprazole depot formulation for the indication of maintenance treatment of schizophrenia in adults is sufficiently complete to permit…
11 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced a development and commercialisation agreement for up to five products in the psychiatry field, including aripiprazole depot formulation and OPC-34712 from Otsuka and up to three highly innovative earlier stage projects from Lundbeck.
28 October 2011 | By H. Lundbeck A/S
Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents in its research and development organisation...
24 October 2011 | By H. Lundbeck A/S
The FDA has approved Onfi™ (clobazam)...
14 October 2011 | By H. Lundbeck A/S
For the first time ever, H. Lundbeck A/S has established its own research centre in China...
5 October 2011 | By H. Lundbeck A/S
Lundbeck has appointed Kristian Sibilitz, Christian Houborg and Lene Andersen as Vice Presidents in Supply Operations & Engineering...
1 July 2011 | By H. Lundbeck A/S
H. Lundbeck A/S has appointed Teddy Hebo Larsen as Senior Vice President of HR...
10 June 2011 | By H. Lundbeck A/S
H. Lundbeck A/S announced that Stig Løkke Pedersen, EVP for Commercial Operations, has decided to resign from his position at Lundbeck in order to pursue new opportunities...